Background: This prospective, comparative study was designed to estimate th
e volume of distribution (V-d) and elimination rate constant (K-e) of genta
micin and to determine the clinical factors affecting the pharmacokinetics
of gentamicin in different stages of sepsis.
Method: Seventy-seven critically ill patients treated with gentamicin for g
ram-negative sepsis were included. These septic patients were divided into
hyperdynamic septic and hypodynamic septic groups according to cardiac inde
x. Twenty-seven patients who received postoperative prophylactic gentamicin
were recruited as controls.
Results: Fifty-two patients in the hyperdynamic septic group had a signific
antly larger V-d than those in the hypodynamic septic and control groups. T
he V-d was correlated significantly with both Acute Physiological Score (AP
S) (r=0.340, P<0.01) and cardiac index (r=0.393, P<0.01). The K-e of gentam
icin correlated significantly with both blood urea nitrogen (BUN) (r= 0.565
, P<0.01) and serum creatinine level (r=0.563, P<0.01).
Conclusion: The increased V-d in the septic patients was related to the sev
erity of illness and magnitude of cardiac output. The K-e of gentamicin was
correlated with the serum creatinine level.